Department of Health Administration, Faculty of Medicine, University of Montreal, Quebec, Canada.
Division of Global Health, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Quebec, Canada.
Cost Eff Resour Alloc. 2011 Feb 9;9:3. doi: 10.1186/1478-7547-9-3.
Although highly effective prevention interventions exist, the epidemic of paediatric HIV continues to challenge control efforts in resource-limited settings. We reviewed the cost-effectiveness of interventions to prevent mother-to-child transmission (MTCT) of HIV in low- and middle-income countries (LMICs). This article presents syntheses of evidence on the costs, effects and cost-effectiveness of HIV MTCT strategies for LMICs from the published literature and evaluates their implications for policy and future research.
Candidate studies were identified through a comprehensive database search including PubMed, Embase, Cochrane Library, and EconLit restricted by language (English or French), date (January 1st, 1994 to January 17th, 2011) and article type (original research). Articles reporting full economic evaluations of interventions to prevent or reduce HIV MTCT were eligible for inclusion. We searched article bibliographies to identify additional studies. Two authors independently assessed eligibility and extracted data from studies retained for review. Study quality was appraised using a modified BMJ checklist for economic evaluations. Data were synthesised in narrative form.
We identified 19 articles published in 9 journals from 1996 to 2010, 16 concerning sub-Saharan Africa. Collectively, the articles suggest that interventions to prevent paediatric infections are cost-effective in a variety of LMIC settings as measured against accepted international benchmarks. In concentrated epidemics where HIV prevalence in the general population is very low, MTCT strategies based on universal testing of pregnant women may not compare well against cost-effectiveness benchmarks, or may satisfy formal criteria for cost-effectiveness but offer a low relative value as compared to competing interventions to improve population health.
Interventions to prevent HIV MTCT are compelling on economic grounds in many resource-limited settings and should remain at the forefront of global HIV prevention efforts. Future cost-effectiveness analyses can help to ensure that pMTCT interventions for LMICs reach their full potential by focussing on unanswered questions in four areas: local assessment of rapidly evolving HIV MTCT options; strategies to improve coverage and reach underserved populations; evaluation of a more comprehensive set of MTCT approaches including primary HIV prevention and reproductive counselling; integration of HIV MTCT and other sexual and reproductive health services.
尽管存在高效的预防干预措施,但在资源有限的环境中,儿科艾滋病的流行仍然对控制工作构成挑战。我们回顾了预防艾滋病毒母婴传播(PMTCT)干预措施在中低收入国家(LMICs)的成本效益。本文从已发表的文献中综合了关于 LMICs 艾滋病毒母婴传播策略的成本、效果和成本效益的证据,并评估了它们对政策和未来研究的意义。
通过全面的数据库搜索,包括 PubMed、Embase、Cochrane 图书馆和 EconLit,以语言(英语或法语)、日期(1994 年 1 月 1 日至 2011 年 1 月 17 日)和文章类型(原始研究)为限制条件,确定候选研究。符合纳入条件的文章是指报告预防或减少艾滋病毒母婴传播干预措施的完整经济评估的文章。我们查阅了文章的参考文献,以确定其他研究。两位作者独立评估纳入研究的资格,并从保留的综述研究中提取数据。使用 BMJ 经济评估检查表评估研究质量。数据以叙述形式综合。
我们从 1996 年至 2010 年的 9 种期刊中确定了 19 篇文章,其中 16 篇来自撒哈拉以南非洲。总的来说,这些文章表明,在各种 LMIC 环境中,预防儿童感染的干预措施在经济上是有效的,符合国际公认的基准。在艾滋病毒在普通人群中的流行率非常低的集中流行地区,基于对孕妇普遍检测的 PMTCT 策略可能与成本效益基准相比不太理想,或者可能符合成本效益的正式标准,但与改善人口健康的其他竞争干预措施相比,相对价值较低。
在许多资源有限的环境中,预防艾滋病毒母婴传播的干预措施在经济上具有吸引力,应继续成为全球艾滋病毒预防工作的重点。未来的成本效益分析可以通过关注四个领域中尚未解决的问题,帮助确保针对 LMICs 的 PMTCT 干预措施发挥其全部潜力:迅速发展的艾滋病毒母婴传播选择的当地评估;提高覆盖面和服务未满足人群的战略;评估包括初级艾滋病毒预防和生殖咨询在内的更全面的母婴传播方法;整合艾滋病毒母婴传播和其他性健康和生殖健康服务。